tradingkey.logo
tradingkey.logo
Search

Treace Medical Concepts Inc

TMCI
Add to Watchlist
4.310USD
-0.070-1.60%
Close 07-31 16:00ETQuotes delayed by 15 min
279.60MMarket Cap
LossP/E TTM

TMCI Income Statement

You can find the annual or quarterly income statement of Treace Medical Concepts Inc here for insights into the performance and operational efficiency of Treace Medical Concepts Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Total revenue
-10.22%47.20M
-9.01%62.52M
11.37%50.21M
6.60%47.39M
2.86%52.57M
10.44%68.71M
10.62%45.09M
5.96%44.45M
21.12%51.11M
25.00%62.21M
23.30%40.76M
40.00%41.95M
45.26%42.20M
48.84%49.77M
52.90%33.05M
45.09%29.97M
55.27%29.05M
38.73%33.44M
51.54%21.62M
166.88%20.65M
66.20%18.71M
43.96%24.10M
60.54%14.27M
-1.86%7.74M
90.78%11.26M
--16.74M
--8.89M
--7.89M
--5.90M
Revenue
-10.22%47.20M
-9.01%62.52M
11.37%50.21M
6.60%47.39M
2.86%52.57M
10.44%68.71M
10.62%45.09M
5.96%44.45M
21.12%51.11M
25.00%62.21M
23.30%40.76M
40.00%41.95M
45.26%42.20M
48.84%49.77M
52.90%33.05M
45.09%29.97M
55.27%29.05M
38.73%33.44M
51.54%21.62M
166.88%20.65M
66.20%18.71M
43.96%24.10M
60.54%14.27M
-1.86%7.74M
90.78%11.26M
--16.74M
--8.89M
--7.89M
--5.90M
Cost of revenue
-8.30%9.79M
-8.41%12.12M
17.36%10.51M
9.73%9.63M
5.43%10.68M
15.36%13.23M
11.95%8.95M
14.41%8.78M
25.97%10.13M
47.97%11.47M
31.33%8.00M
45.06%7.67M
56.71%8.04M
44.37%7.75M
43.36%6.09M
34.15%5.29M
54.19%5.13M
5.59%5.37M
45.93%4.25M
89.16%3.94M
39.26%3.33M
54.84%5.08M
63.82%2.91M
40.50%2.08M
119.98%2.39M
--3.28M
--1.78M
--1.48M
--1.09M
Operating expenses
-5.56%64.36M
-0.68%68.44M
9.42%65.89M
-2.24%64.36M
-2.75%68.15M
-0.12%68.91M
2.81%60.22M
19.69%65.84M
25.20%70.08M
29.53%68.99M
32.01%58.58M
31.28%55.01M
50.69%55.97M
36.45%53.27M
63.86%44.37M
69.60%41.90M
84.71%37.14M
90.70%39.04M
88.98%27.08M
166.91%24.70M
61.45%20.11M
40.36%20.47M
26.05%14.33M
-0.26%9.26M
61.36%12.46M
--14.58M
--11.37M
--9.28M
--7.72M
R&D expenses
-16.90%4.62M
-12.82%4.54M
-5.70%4.68M
6.61%5.50M
5.76%5.56M
25.48%5.21M
14.09%4.96M
46.26%5.16M
54.13%5.26M
10.75%4.15M
14.50%4.35M
18.16%3.53M
11.80%3.41M
11.02%3.75M
49.74%3.80M
23.20%2.98M
63.38%3.05M
75.70%3.38M
67.90%2.54M
146.89%2.42M
30.36%1.87M
26.45%1.92M
2.44%1.51M
-1.80%981.00K
33.18%1.43M
--1.52M
--1.48M
--999.00K
--1.08M
Depreciation, depletion, and amortization
-63.47%899.00K
25.53%2.81M
28.79%2.78M
21.74%2.58M
28.92%2.46M
24.28%2.24M
34.81%2.16M
92.36%2.12M
106.60%1.91M
96.29%1.80M
248.58%1.60M
160.05%1.10M
176.65%924.00K
31.07%917.00K
142.86%459.00K
310.68%423.00K
185.47%334.00K
--699.60K
--189.00K
--103.00K
--117.00K
----
----
----
----
----
----
----
----
Operating profit
-10.17%-17.17M
-2802.94%-5.92M
-3.58%-15.68M
20.62%-16.97M
17.85%-15.58M
96.99%-204.00K
15.06%-15.13M
-63.82%-21.38M
-37.69%-18.97M
-93.94%-6.78M
-57.43%-17.82M
-9.38%-13.05M
-70.16%-13.78M
37.52%-3.50M
-107.29%-11.32M
-194.57%-11.93M
-477.46%-8.10M
-254.02%-5.60M
-8566.67%-5.46M
-167.04%-4.05M
-16.93%-1.40M
68.24%3.63M
97.46%-63.00K
-8.82%-1.52M
34.08%-1.20M
--2.16M
---2.48M
---1.39M
---1.82M
Net non-operating interest income (expenses)
Non-operating interest income
-40.43%501.00K
-41.38%527.00K
-40.58%634.00K
-43.68%775.00K
-45.21%841.00K
-47.40%899.00K
-32.04%1.07M
-30.08%1.38M
3.79%1.54M
113.89%1.71M
273.81%1.57M
1402.29%1.97M
16333.33%1.48M
15880.00%799.00K
8300.00%420.00K
2083.33%131.00K
800.00%9.00K
150.00%5.00K
--5.00K
100.00%6.00K
-96.97%1.00K
-71.43%2.00K
----
-93.48%3.00K
6.45%33.00K
--7.00K
--27.00K
--46.00K
--31.00K
Non-operating interest expense
19.76%1.57M
2.74%1.35M
1.90%1.34M
0.69%1.32M
-0.46%1.31M
0.77%1.31M
1.31%1.31M
2.34%1.31M
2.49%1.32M
-0.53%1.30M
8.91%1.30M
35.52%1.28M
35.12%1.28M
27.53%1.31M
23.57%1.19M
-8.86%946.00K
-7.76%951.00K
-3.93%1.03M
-62.85%963.00K
126.64%1.04M
133.79%1.03M
279.43%1.07M
980.00%2.59M
115.02%458.00K
316.04%441.00K
--282.00K
--240.00K
--213.00K
--106.00K
Special income (expenses)
----
---2.74M
--33.00K
----
----
--0.00
----
----
----
100.00%0.00
--0.00
100.00%0.00
----
---300.00K
--0.00
---4.48M
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
111.54%275.00K
-25.42%88.00K
360.00%92.00K
8.93%122.00K
75.68%130.00K
22.92%118.00K
-13.04%20.00K
17.89%112.00K
-42.19%74.00K
193.20%96.00K
151.11%23.00K
3266.67%95.00K
6300.00%128.00K
-10400.00%-103.00K
---45.00K
---3.00K
--2.00K
--1.00K
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-12.81%-17.96M
-1775.05%-9.39M
-6.04%-16.29M
17.96%-17.40M
14.75%-15.92M
92.02%-501.00K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
33.34%-4.41M
-89.05%-12.13M
-239.05%-17.23M
-271.55%-9.04M
-357.95%-6.62M
-141.73%-6.42M
-157.76%-5.08M
-51.34%-2.43M
36.13%2.57M
1.48%-2.66M
-26.33%-1.97M
15.15%-1.61M
--1.89M
---2.69M
---1.56M
---1.89M
Income after tax
-12.81%-17.96M
-1775.05%-9.39M
-6.04%-16.29M
17.96%-17.40M
14.75%-15.92M
92.02%-501.00K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
33.34%-4.41M
-89.05%-12.13M
-239.05%-17.23M
-271.55%-9.04M
-357.95%-6.62M
-141.73%-6.42M
-157.76%-5.08M
-51.34%-2.43M
36.13%2.57M
1.48%-2.66M
-26.33%-1.97M
15.15%-1.61M
--1.89M
---2.69M
---1.56M
---1.89M
Net income from continuous operations
-12.81%-17.96M
-1775.05%-9.39M
-6.04%-16.29M
17.96%-17.40M
14.75%-15.92M
92.02%-501.00K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
33.34%-4.41M
-89.05%-12.13M
-239.05%-17.23M
-271.55%-9.04M
-357.95%-6.62M
-141.73%-6.42M
-157.76%-5.08M
-51.34%-2.43M
36.13%2.57M
1.48%-2.66M
-26.33%-1.97M
15.15%-1.61M
--1.89M
---2.69M
---1.56M
---1.89M
Net income attributable to controlling interests
-12.81%-17.96M
-1775.05%-9.39M
-6.04%-16.29M
17.96%-17.40M
14.75%-15.92M
92.02%-501.00K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
33.34%-4.41M
-89.05%-12.13M
-236.47%-17.23M
-248.88%-9.04M
-375.22%-6.62M
-127.91%-6.42M
-140.24%-5.12M
-46.74%-2.59M
39.50%2.41M
1.40%-2.82M
-23.88%-2.13M
13.99%-1.77M
--1.72M
---2.86M
---1.72M
---2.05M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
-100.00%0.00
-75.63%39.00K
0.00%158.00K
0.00%161.00K
0.00%161.00K
0.00%160.00K
0.00%158.00K
--161.00K
--161.00K
--160.00K
--158.00K
Net income attributable to common shareholders
-12.81%-17.96M
-1775.05%-9.39M
-6.04%-16.29M
17.96%-17.40M
14.75%-15.92M
92.02%-501.00K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
33.34%-4.41M
-89.05%-12.13M
-236.47%-17.23M
-248.88%-9.04M
-375.22%-6.62M
-127.91%-6.42M
-140.24%-5.12M
-46.74%-2.59M
39.50%2.41M
1.40%-2.82M
-23.88%-2.13M
13.99%-1.77M
--1.72M
---2.86M
---1.72M
---2.05M
Basic earnings per share
-9.43%-0.28
-1729.48%-0.15
-3.89%-0.26
19.16%-0.28
15.93%-0.25
92.10%-0.01
13.27%-0.25
-70.87%-0.34
-31.92%-0.30
-28.12%-0.10
-30.02%-0.28
35.84%-0.20
-39.01%-0.23
35.37%-0.08
-79.96%-0.22
-199.24%-0.31
-140.88%-0.16
-357.89%-0.12
-117.97%-0.12
-146.46%-0.10
-95.60%-0.07
39.52%0.05
1.41%-0.06
-23.90%-0.04
13.97%-0.03
--0.03
---0.06
---0.03
---0.04
Diluted earnings per share
-9.43%-0.28
-1729.48%-0.15
-3.89%-0.26
19.16%-0.28
15.93%-0.25
92.10%-0.01
13.27%-0.25
-70.87%-0.34
-31.92%-0.30
-28.12%-0.10
-30.02%-0.28
35.84%-0.20
-39.01%-0.23
35.37%-0.08
-79.96%-0.22
-199.24%-0.31
-140.88%-0.16
-357.89%-0.12
-117.97%-0.12
-146.46%-0.10
-95.60%-0.07
39.52%0.05
1.41%-0.06
-23.90%-0.04
13.97%-0.03
--0.03
---0.06
---0.03
---0.04
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Treace Medical Concepts Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing TMCI stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Treace Medical Concepts Inc's revenue at year end?

Treace Medical Concepts Inc reported 212.69M in revenue for fiscal year 2025, up from 209.36M in the previous year.

How much revenue did Treace Medical Concepts Inc report in the most recent quarter?

Treace Medical Concepts Inc reported 47.20M in revenue for the most recent quarter, an increase of -10.22% year over year.

What was Treace Medical Concepts Inc's net income for the year?

Treace Medical Concepts Inc posted -59.00M in net income for fiscal year 2025.

How much net income did Treace Medical Concepts Inc post in the last quarter?

Treace Medical Concepts Inc reported -17.96M in net income for the latest quarter。

What was Treace Medical Concepts Inc's annual operating profit?

Treace Medical Concepts Inc's operating income was -54.15M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.